XCUR
Exicure Inc
Halal Rating :
Last Price
$9.90
Last updated:
Market Cap
-
7D Change
25.32%
1 Year Change
1664.71%
Company Overview
Industries
Exchange
Next Earnings Date
Exicure, Inc. is a biotechnology company that develops gene regulatory and immunotherapeutic drugs using spherical nucleic acid (SNA) technology. The company focuses on developing treatments for neurological disorders and other diseases.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2024 | $500000.0 | $1.34m | - | - | 0.00% | 0.00% |
Company Impact
Help us evaluate Exicure Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.